Agonists of proteinase-activated receptor-2 affect transendothelial migration and apoptosis of human neutrophils

Experimental Dermatology

Volumn 16, Issue 10, 2007, Pages 799-806

  Shpacovitch, Victoria M ^a   Seeliger, Stephan ^a   Huber lang, Markus ^b   Balkow, Sandra ^a   Feld, Micha ^a   Hollenberg, Morley D ^c   Sarma, Vidya J ^d   Ward, Peter A ^d   Strey, Anke ^a   Gerke, Volker ^a   Sommerhoff, Christian P ^e   Vergnolle, Nathalie ^c   Steinhoff, Martin ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

Inflammation; Innate immunity; Leukocyte; Proteinase activated receptor; Skin

Indexed keywords

CD64 ANTIGEN; FC RECEPTOR; GAMMA INTERFERON; PROTEINASE ACTIVATED RECEPTOR 2; SERINE PROTEINASE;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CELL PROTECTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; PROTEIN EXPRESSION; SEPSIS; WOUND HEALING;

APOPTOSIS; CELL MEMBRANE; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; NEUTROPHILS; OLIGOPEPTIDES; RECEPTOR, PAR-2; RECEPTORS, IGG; SEPSIS; TIME FACTORS; TRYPSIN; TRYPTASES;

EID: 34548512255     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2007.00605.x     Document Type: Article

References (52)

1. Hollenberg M D, Compton S J. International Union of Pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol Rev 2002: 54: 203-217.
2. Steinhoff M, Buddenkotte J, Shpacovitch V et al. Proteinase-activated receptors: Transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 2005: 26: 1-43.
3. Molino M, Barnathan E S, Numerof R et al. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem 1997: 272: 4043-4049.
4. Nystedt S, Emilsson K, Larsson A K, Strombeck B, Sundelin J. Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. Eur J Biochem 1995: 232: 84-89.
5. Lourbakos A, Chinni C, Thompson P et al. Cleavage and activation of proteinase-activated receptor-2 on human neutrophils by gingipain-R from Porphyromonas gingivalis. FEBS Lett 1998: 435: 45-48.
6. Sun G, Stacey M A, Schmidt M, Mori L, Mattoli S. Interaction of mite allergens Der p3 and Der p9 with protease-activated receptor-2 expressed by lung epithelial cells. J Immunol 2001: 167: 1014-1021.
7. Uehara A, Muramoto K, Takada H, Sugawara S. Neutrophil serine proteinases activate human nonepithelial cells to produce inflammatory cytokines through protease-activated receptor 2. J Immunol 2003: 170: 5690-5696.
8. Steinhoff M, Corvera C U, Thoma M S et al. Proteinase-activated receptor-2 in human skin: Tissue distribution and activation of keratinocytes by mast cell tryptase. Exp Dermatol 1999: 8: 282-294.
9. Miike S, McWilliam A S, Kita H. Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2. J Immunol 2001: 167: 6615-6622.
10. Colognato R, Slupsky J R, Jendrach M, Burysek L, Syrovets T, Simmet T. Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells. Blood 2003: 102: 2645-2652.
11. Howells G L, Macey M G, Chinni C et al. Proteinase-activated receptor-2: expression by human neutrophils. J Cell Sci 1997: 110: 881-887.
12. Moormann C, Artuc M, Pohl E et al. Functional characterization and expression analysis of the proteinase-activated receptor-2 in human cutaneous mast cells. J Invest Dermatol 2006: 126: 746-755.
13. Maurer M, Metz M. The status quo and quo vadis of mast cells. Exp Dermatol 2005: 14: 923-929.
14. Stander S, Steinhoff M. Pathophysiology of pruritus in atopic dermatitis: An overview. Exp Dermatol 2002: 11: 12-24.
15. Ossovskaya V S, Bunnett N W. Protease-activated receptors: Contribution to physiology and disease. Physiol Rev 2004: 84: 579-621.
16. Noorbakhsh F, Tsutsui S, Vergnolle N et al. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J Exp Med 2006: 203: 425-435.
17. Seeliger S, Derian C K, Vergnolle N et al. Proinflammatory role of proteinase-activated receptor-2 in humans and mice during cutaneous inflammation in vivo. FASEB J 2003: 17: 1871-1885.
18. Schmidlin F, Amadesi S, Dabbagh K et al. Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway. J Immunol 2002: 169: 5315-5321.
19. Ferrell W R, Lockhart J C, Kelso E B et al. Essential role for proteinase-activated receptor-2 in arthritis. J Clin Invest 2003: 111: 35-41.
20. Fiorucci S, Mencarelli A, Palazzetti B et al. Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc Natl Acad Sci U S A 2001: 98: 13936-13941.
21. Namkung W, Han W, Luo X et al. Protease-activated receptor 2 exerts local protection and mediates some systemic complications in acute pancreatitis. Gastroenterology 2004: 126: 1844-1859.
22. Riedemann N C, Guo R F, Ward P A. The enigma of sepsis. J Clin Invest 2003: 112: 460-467.
23. McGirt L Y, Beck L A. Innate immune defects in atopic dermatitis. J Allergy Clin Immunol 2006: 118: 202-208.
24. Ellis T N, Beaman B L. Interferon-gamma activation of polymorphonuclear neutrophil function. Immunology 2004: 112: 2-12.
25. Cassatella M A, Huber V, Calzetti F et al. Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators. J Leukoc Biol 2006: 79: 123-132.
26. Schroder K, Hertzog P J, Ravasi T, Hume D A. Interferon-gamma: An overview of signals, mechanisms and functions. J Leukoc Biol 2004: 75: 163-189.
27. Schiller M, Metze D, Luger T A, Grabbe S, Gunzer M. Immune response modifiers-mode of action. Exp Dermatol 2006: 15: 331-341.
28. Vincent J L, Sun Q, Dubois M J. Clinical trials of immunomodulatory therapies in severe sepsis and septic shock. Clin Infect Dis 2002: 34: 1084-1093.
29. Shpacovitch V M, Varga G, Strey A et al. Agonists of proteinase-activated receptor-2 modulate human neutrophil cytokine secretion, expression of cell adhesion molecules, and migration within 3-D collagen lattices. J Leukoc Biol 2004: 76: 388-398.
30. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. Neutrophils: Molecules, functions and pathophysiological aspects. Lab Invest 2000: 80: 617-653.
31. Edwards S. Biochemistry and Physiology of the Neutrophil. New York: Cambridge University Press, 1994.
32. Shpacovitch V M, Brzoska T, Buddenkotte J et al. Agonists of proteinase-activated receptor 2 induce cytokine release and activation of nuclear transcription factor kappaB in human dermal microvascular endothelial cells. J Invest Dermatol 2002: 118: 380-385.
33. Vergnolle N, Macnaughton W K, Al-Ani B, Saifeddine M, Wallace J L, Hollenberg M D. Proteinase-activated receptor 2 (PAR2)-activating peptides: Identification of a receptor distinct from PAR2 that regulates intestinal transport. Proc Natl Acad Sci U S A 1998: 95: 7766-7771.
34. Bone R C, Balk R A, Cerra F B et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992: 101: 1644-1655.
35. Feige U, Overwien B, Sorg C. Purification of human blood monocytes by hypotonic density gradient centrifugation in Percoll. J Immunol Methods 1982: 54: 309-315.
36. Rohnelt R K, Hoch G, Reiss Y, Engelhardt B. Immunosurveillance modelled in vitro: Naive and memory T cells spontaneously migrate across unstimulated microvascular endothelium. Int Immunol 1997: 9: 435-450.
37. Homburg C H, de Haas M, von dem Borne A E, Verhoeven A J, Reutelingsperger C P, Roos D. Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood 1995: 85: 532-540.
38. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992: 80: 2012-2020.
39. Nystedt S, Ramakrishnan V, Sundelin J. The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor. J Biol Chem 1996: 271: 14910-14915.
40. Muhl H, Pfeilschifter J. Anti-inflammatory properties of pro-inflammatory interferon-gamma. Int Immunopharmacol 2003: 3: 1247-1255.
41. Camerer E, Huang W, Coughlin S R. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A 2000: 97: 5255-5260.
42. Camerer E, Kataoka H, Kahn M, Lease K, Coughlin S R. Genetic evidence that protease-activated receptors mediate factor Xa signaling in endothelial cells. J Biol Chem 2002: 277: 16081-16087.
43. Jin E, Fujiwara M, Pan X et al. Protease-activated receptor (PAR)-1 and PAR-2 participate in the cell growth of alveolar capillary endothelium in primary lung adenocarcinomas. Cancer 2003: 97: 703-713.
44. de Haas M, Vossebeld P J, von dem Borne A E, Roos D. Fc gamma receptors of phagocytes. J Lab Clin Med 1995: 126: 330-341.
45. Wagner J G, Roth R A. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol Rev 2000: 52: 349-374.
46. Varani J, Ward P A. Mechanisms of neutrophil-dependent and neutrophil-independent endothelial cell injury. Biol Signals 1994: 3: 1-14.
47. Lentsch A B, Ward P A. Regulation of inflammatory vascular damage. J Pathol 2000: 190: 343-348.
48. Savill J. Apoptosis in resolution of inflammation. J Leukoc Biol 1997: 61: 375-380.
49. McKenzie S E, Schreiber A D. Fc gamma receptors in phagocytes. Curr Opin Hematol 1998: 5: 16-21.
50. Goulding N J, Knight S M, Godolphin J L, Guyre P M. Increase in neutrophil Fc gamma receptor I expression following interferon gamma treatment in rheumatoid arthritis. Ann Rheum Dis 1992: 51: 465-468.
51. Davis B H, Olsen S H, Ahmad E, Bigelow N C. Neutrophil CD64 is an improved indicator of infection or sepsis in emergency department patients. Arch Pathol Lab Med 2006: 130: 654-661.
52. Steinhoff M, Griffiths C M E, Church M K, Luger T A. Inflammation. In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook's Textbook of Dermatology, 7th edn. Oxford: Blackwell Publishing Ltd., 2004.